Robledo O, Auguste P, Coupey L, Praloran V, Chevalier S, Pouplard A, Gascan H
Laboratoire de Biologie Cellulaire, CHU Angers, France.
J Neurochem. 1996 Apr;66(4):1391-9. doi: 10.1046/j.1471-4159.1996.66041391.x.
Leukemia inhibitory factor (LIF) and ciliary neurotrophic factor (CNTF) share common components in their multimeric receptors. Both cytokine receptors contain gp130/interleukin-6-receptor transducer as well as gp190/low affinity LIF receptor. For CNTF, addition of a third subunit, or alpha subunit, defines the high-affinity CNTF receptor. In the present study, we analyzed the binding interactions of LIF and CNTF in human cell lines and showed a mutual displacement for LIF and CNTF toward the trimeric high-affinity CNTF receptor. Similar results were obtained in the JEG cell line, which only expressed the gp130/gp190 high-affinity LIF receptor, by adding a soluble form of the alpha CNTF receptor to the system to reconstitute the high-affinity-type CNTF receptor. The different receptor subunits were then expressed separately in transfected cells and their binding capacities analyzed. The results showed that the heterocomplex CNTF/alpha CNTF receptor bound to gp130 with an affinity of 3-5 x 10(-10)M, whereas LIF interacted mainly with gp190. In summary, the observed competition between LIF and CNTF does not result from the binding to a common site or receptor subunit, but rather to the interaction of the three receptor components to create a conformational site common to both LIF and CNTF.
白血病抑制因子(LIF)和睫状神经营养因子(CNTF)在其多聚体受体中具有共同成分。两种细胞因子受体都包含gp130/白细胞介素-6受体转导子以及gp190/低亲和力LIF受体。对于CNTF而言,添加第三个亚基,即α亚基,可定义高亲和力CNTF受体。在本研究中,我们分析了LIF和CNTF在人细胞系中的结合相互作用,并显示LIF和CNTF对三聚体高亲和力CNTF受体存在相互置换。通过向系统中添加可溶性形式的αCNTF受体以重建高亲和力型CNTF受体,在仅表达gp130/gp190高亲和力LIF受体的JEG细胞系中也获得了类似结果。然后将不同的受体亚基分别在转染细胞中表达并分析其结合能力。结果表明,CNTF/αCNTF受体异源复合物与gp130的结合亲和力为3-5×10⁻¹⁰M,而LIF主要与gp190相互作用。总之,观察到的LIF和CNTF之间的竞争并非源于与共同位点或受体亚基的结合,而是源于三种受体成分的相互作用,从而产生了LIF和CNTF共有的构象位点。